Skip to main content
SABS logo

SABS · SAB Biotherapeutics, Inc.

Track SABS — free
$3.88 +0.07 (+1.84%) At close · Aug 26
Market Cap
$353.03M
Shares
90.99M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 92
Total Value: $268,269,128
Total Shares: 69,687,206

Institutional Ownership Trend

22 quarters

Holder Concentration

Across 92 13F filers · Δ vs Mar 31, 2026
Top Holder
11.6%
Sep 2023 → Jun 2026 · range 11.6% – 47.7%
−4.9 pts
Top 5
47.5%
Sep 2023 → Jun 2026 · range 47.5% – 93.3%
−2.4 pts
Top 10
70.0%
Sep 2023 → Jun 2026 · range 70.0% – 99.0%
−2.3 pts
HHI
618
Sep 2023 → Jun 2026 · range 618 – 3,090
Broadly held−99

Quarterly Activity

vs Mar 31, 2026
New
29
Increased
31
Decreased
17
Sold Out
20
Unchanged
15
Holder count: +9
Institutional value: +0.9%
Shares held: -0.8%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 99 of 99
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 96 filings 90 filers Visit website Investor relations